About ExBiome
ExBiome is a company based in Amsterdam (Netherlands) founded in 2015 by James Simon, Michiel Pegtel, and Danijela Koppers-Lalic. It operates as a B2B. ExBiome operates in a competitive market with competitors including Miroculus, Abingdon Health, Mirvie, Epic Sciences and OncoCyte, among others.
- Headquarter Amsterdam, Netherlands
- Founders James Simon, Michiel Pegtel, Danijela Koppers-Lalic
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ExBiome
Detailed funding history for ExBiome
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ExBiome
Investment portfolio details for ExBiome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ExBiome
Detailed financials for ExBiome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Exbiome Comparisons
Peer comparison for ExBiome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ExBiome
ExBiome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Miroculus, Abingdon Health, Mirvie, Epic Sciences and OncoCyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
MicroRNA profiling platform is developed to detect genes in samples.
|
|
| Locked | Locked | Locked |
Developer of immunoassays for diagnostic purposes
|
|
| Locked | Locked | Locked |
Non-invasive blood tests for prenatal fetal health predictions are offered.
|
|
| Locked | Locked | Locked |
Non-invasive tests for detecting circulating tumor cells are provided.
|
|
| Locked | Locked | Locked |
Non-invasive diagnostic test solutions for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Molecular diagnostic testing for endometriosis is provided via saliva-based biomarkers.
|
Detailed competitors of ExBiome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Exbiome
Complete news archive for ExBiome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ExBiome
ExBiome was founded in 2015.
ExBiome is headquartered in Amsterdam, Netherlands.
James Simon is the current CEO of ExBiome. They have also founded this company.
ExBiome develops innovative diagnostic technologies for cancer detection from blood samples, focusing on providing healthcare solutions, advancing biotech innovations, medical diagnostics, and cancer detection. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
ExBiome's top competitors include Abingdon Health, Mirvie and OncoCyte.